The information on this site is not intended or implied to be a substitute for professional medical advice, diagnosis or treatment. Content within the patient forum is user-generated and has not been reviewed by medical professionals. Other sections of the Melanoma Research Foundation website include information that has been reviewed by medical professionals as appropriate. All medical decisions should be made in consultation with your doctor or other qualified medical professional.

ccbreeding

Topics Engaged In

Viewing 6 topics - 1 through 6 (of 6 total)

- TOPIC
- Zadaxin and low dose naltrexone
  Started by: bball General Melanoma Community
- 2
- 6
- kreedkall
  
  11 years, 8 months ago
- Packing for MDA – 6th trip since diagnosis !
  Started by: Snickers60 General Melanoma Community
- 4
- 12
- ccbreeding
  
  12 years, 9 months ago
- skin graft on foot sole
  Started by: Shimian General Melanoma Community
- 4
- 18
- Bosandi
  
  13 years, 7 months ago
- Frustrated with surgery
  Started by: killmel General Melanoma Community
- 6
- 21
- jcraigdawson
  
  13 years, 7 months ago
- Melanoma and cervix
  Started by: ccbreeding General Melanoma Community
- 2
- 9
- JerryfromFauq
  
  13 years, 7 months ago
- Dallas Mel Centers &/or Doctors
  Started by: Rocco General Melanoma Community
- 4
- 8
- jcraigdawson
  
  13 years, 10 months ago

Viewing 6 topics - 1 through 6 (of 6 total)

The MRF Patient Forum is the oldest and largest online community of people affected by melanoma. It is designed to provide peer support and information to caregivers, patients, family and friends. There is no better place to discuss different parts of your journey with this cancer and find the friends and support resources to make that journey more bearable.

The information on the forum is open and accessible to everyone. To add a new topic or to post a reply, you must be a registered user. Please note that you will be able to post both topics and replies anonymously even though you are logged in. All posts must abide by MRF posting policies.